Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ENTERO vs MCK, COR, CAH: OCF Margin % Comparison
For the Medical Distribution subindustry, Entero Healthcare Solutions's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entero Healthcare Solutions OCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Entero Healthcare Solutions's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entero Healthcare Solutions (NSE:ENTERO) has a OCF Margin % of 0.00% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Entero Healthcare Solutions and its competitors. According to the industry distribution chart, Entero Healthcare Solutions ranks #63 out of 117 companies in the Medical Distribution industry, placing it in the top 53.8%.
Is Entero Healthcare Solutions' OCF Margin % too high?
Entero Healthcare Solutions' current OCF Margin % is 0.00%. Based on the distribution chart, Entero Healthcare Solutions ranks #63 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Entero Healthcare Solutions has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' OCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Entero Healthcare Solutions ranks #63 out of 117 companies for OCF Margin %. This places Entero Healthcare Solutions in the lower half of its industry. The industry median OCF Margin % is 1.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Distribution company?
The median OCF Margin % among Medical Distribution companies is 1.73, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Entero Healthcare Solutions and its competitors. For the Medical Distribution industry, the median OCF Margin % is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (NSE:ENTERO) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,734.04, compared to a current price of ₹1,448.00 — trading 16.5% below its estimated fair value. The current OCF Margin % is 0.00%. Entero Healthcare Solutions' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current OCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?
Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be undervalued.
The current stock price of ₹1,448.00 is trading 16.5% below its estimated GF Value™ of ₹1,734.04.
GuruFocus considers Entero Healthcare Solutions to be Modestly Undervalued.
Key valuation signals for NSE:ENTERO:
OCF Margin %: 0.00%
GF Value™: ₹1,734.04 vs. price of ₹1,448.00 (16.5% below fair value)
No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
67GF Score
Get the complete analysis for NSE:ENTERO
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ENTERO has been successfully added to your 
